Sorrento To Provide Manufacturing Support To Celularity As CYNK-001 Trial For Covid-19 Begins Enrolling Patients Read more
Novartis announces plan to initiate clinical study of Jakavi in severe COVID-19 patients and establish international compassionate use program Read more
Novartis announces mutual agreement to terminate sale of Sandoz US generic oral solids, dermatology portfolio to Aurobindo Read more
Fate Therapeutics Announces Worldwide Collaboration with Janssen for Novel iPSC-derived Cell-based Cancer Immunotherapies Read more
ImmunityBio Combines Supercomputing Power with Microsoft Azure to Target Infection “Doorway” of the Coronavirus Read more
Citius Signs Exclusive Option with Novellus to License Novel Stem-Cell Therapy for ARDS Associated with COVID-19 Read more
Lilly and Sitryx Announce Licensing and Research Collaboration to Discover and Develop New Immunometabolic Medicines Read more